dc.description.abstract |
A foremost step towards controlled and targeted administration of therapeutic agents is
development of new drug delivery systems. Oral administration is mostly preferred and
desired as a non-invasive mean of providing drug at controlled rate. In present research work,
hydrogels were prepared for controlled release of captopril, an angiotensin converting
enzyme (ACE) inhibitor, used for the treatment of hypertension. Three types of hydrogel
formulations were prepared by different proportions of polymers and monomers. A chemical
crosslinking method, free radical polymerization was selected for synthesis of polymeric
networks, involving use of thermostatic water bath as well as induction by microwave
radiations. A microwave assisted hydrogel synthesis, was used for preparation of
hydroxypropyl methylcellulose-graft-poly(vinyl alcohol)-co-poly(acrylic acid) copolymeric
network. N,N-methylenebisacrylamide and potassium persulfate (KPS) were used as
crosslinking agent and initiator, respectively. Formulations with same combinations of
polymers and monomers were also prepared by utilizing conventional thermostatic water
bath. The hydrogels obtained by these techniques were compared with each other in terms of
morphological properties, swelling ratios, drug loading and drug release behavior.
The hydrogel formulations were also prepared by crosslinking of 2-acrylamido-2-methyl-1-
propanesulfonic acid (AMPS) and acrylic acid with hydroxypropyl methylcellulose (HPMC).
These hydrogels had shown higher ability to absorb and retain aqueous solutions and solute
particles. Another type of polymeric network was synthesized under influence of microwaves
radiations, with lower initiator concentration, by crosslinking of poly(vinyl alcohol) (PVA)
with 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS). They have ability to exhibit
relatively higher swelling behavior at pH 2 in comparison to pH 7.4 and have gastro retentive
characteristics. Due to their massive swelling tendencies, these could be retained in stomach
and unable to pass through next segment of gastrointestinal tract. Thus, after oral
administration of captopril loaded hydrogels, they could have ability to release drug
continuously at acidic pH of stomach, in a control manner for longer time periods. The
results of drug release are according to swelling powers of formed copolymeric hydrogels.
6
All types of hydrogel formulations prepared were evaluated by in-vitro and in-vivo analytical
procedures. The in-vitro characterization was done by Fourier Transform Infrared
Spectroscopy (FT-IR), scanning electron microscopy (SEM), X-ray diffraction (XRD),
thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), swelling
properties, drug loading and release. The drug release was evaluated by the application of
zero order kinetics, first order kinetics, Higuchi model, Korsmayer-Peppas model and
Weibull model.
The hydrogels selected on the basis of their in-vitro evaluation were subjected to in-vivo
characterization. High performance liquid chromatography (HPLC) method, with UV
detector was utilized for in-vivo characterization. The study was performed on twenty four
rabbits and liquid-liquid extraction procedure was used for separation of captopril from
plasma samples. The bioavailability and pharmacokinetic parameters were determined by
kinetica (version 5.0). The maximum concentration (Cmax) of captopril was reduced while
time to reach maximum concentration (Tmax) was increased by hydrogels in comparison to
control (free drug enclosed in hard gelatin capsules). The values of area under curve AUC
(calculated by trapezoidal rule) and elimination half-life were higher for controlled release
hydrogel formulations than control. The drug could be available for longer periods of time
after administration of captopril loaded hydrogels, maintaining optimum concentration in
blood, exerting its efficacious effects as an antihypertensive therapeutic agent. |
en_US |